If you have been reading about NMNAT and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-10-16. Numbers and descriptions here follow the published literature rather than marketing material.
Two enzymatic steps define the canonical route from nicotinamide to NAD+. Nicotinamide phosphoribosyltransferase, known as NAMPT, produces NMN from nicotinamide and phosphoribosyl pyrophosphate. NMN adenylyltransferases, or NMNAT enzymes, then couple NMN with ATP to form NAD+. Whether intact NMN crosses cell membranes efficiently remains an active area of investigation; some studies propose direct transport, while others emphasize extracellular dephosphorylation to nicotinamide riboside followed by uptake. The relative contribution of each route likely depends on cell type, tissue, and experimental conditions.
Trace amounts of NMN have been reported in certain plant foods, including edamame, avocado, broccoli, cucumber, and cabbage. Reported concentrations vary widely because analytical methods differ and food matrices complicate extraction. Endogenous production in cells is generally considered more quantitatively important than dietary intake, though precise human turnover rates are difficult to establish. Commercial NMN for research or consumer products is commonly made through enzymatic synthesis or chemical phosphorylation routes. Regulatory classification differs by country; in some jurisdictions NMN is sold as a supplement, while in others it is treated as a novel food ingredient or restricted substance.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. As an intermediate in the NAD+ salvage pathway, NMN is converted to nicotinamide adenine dinucleotide, a coenzyme central to cellular redox reactions. NAD+ also serves as a substrate for enzymes involved in DNA repair, stress responses, and metabolic regulation. The compound is therefore part of normal cellular biochemistry rather than an exclusively synthetic molecule.
Chemically, NMN is described by the molecular formula C11H15N2O8P and a molecular mass near 334.22 g/mol. The beta anomer has a CAS Registry Number of 1094-61-7. It is typically supplied as a white to off-white powder for laboratory use. The molecule carries a phosphate group and a positively charged nicotinamide ring, giving it polar and water-soluble character. These properties influence how it is detected, purified, and stored in research and analytical laboratories.
Nicotinamide mononucleotide, abbreviated NMN, is a nucleotide composed of nicotinamide, ribose, and phosphate. Its structure links nicotinamide to D-ribose 5-phosphate through a glycosidic bond, placing it in the pyridine nucleotide family. The compound exists in alpha and beta anomeric forms, and the beta form is the one used in NAD+ biosynthesis. NMN is not a protein or a hormone; it is a small water-soluble molecule that occurs in living cells as a metabolic intermediate.
Natural sources of NMN include mammals, plants, and microorganisms, where it functions as an intermediate in NAD+ salvage and biosynthesis pathways. In mammals, the enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferase. Some foods contain measurable NMN, but reported amounts vary widely by species, tissue, and analytical method. The extent to which dietary NMN contributes to cellular NAD+ pools remains an open research question.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C11H15N2O8P | Canonical beta anomer; charge state depends on pH. |
| Molar mass | 334.22 g/mol | Calculated for the neutral formula. |
| CAS Registry Number | 1094-61-7 | Common identifier for beta-nicotinamide mononucleotide. |
| Appearance | White to off-white powder or crystals | Varies with purity, hydration, and polymorphism. |
| Solubility | Freely soluble in water; low solubility in nonpolar solvents | Reported values depend on salt form and temperature. |
In the salvage pathway, NMN is generated from nicotinamide and 5-phosphoribosyl-1-pyrophosphate by the enzyme nicotinamide phosphoribosyltransferase. A second route produces NMN from nicotinamide riboside through phosphorylation by nicotinamide riboside kinases. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferases, often called NMNAT enzymes. This stepwise route allows cells to recycle nicotinamide and maintain NAD+ levels under changing metabolic conditions. The relative contribution of each route varies by tissue, species, and physiological state, and it remains an active area of research.
Research on NMN has expanded because NAD+ concentrations decline with age in some tissues and because NAD+ participates in energy metabolism, DNA repair, and signaling. Animal studies have reported changes in NAD+ levels after NMN administration, but human data are more limited and often focus on safety, pharmacokinetics, and biomarker changes. Questions remain about oral absorption, tissue distribution, and whether changes in blood NAD+ reflect changes inside specific organs. NMN is not an approved drug, and claims about its clinical effects should be distinguished from established biochemical findings.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide found in the cells of many organisms. Its structure consists of a nicotinamide group linked to a ribose sugar that carries a phosphate group. NMN is an intermediate in the biosynthesis of nicotinamide adenine dinucleotide, or NAD+, a coenzyme involved in many metabolic reactions. The abbreviation usually refers to the beta anomer, though related forms can exist. In scientific literature, NMN is distinct from nicotinamide riboside, another NAD+ precursor.
In the NAD+ salvage pathway, the enzyme NAMPT converts nicotinamide and a phosphate-donor molecule into NMN. A second enzyme, NMNAT, then converts NMN into NAD+. Nicotinamide riboside can also enter this route after being converted to NMN by nicotinamide riboside kinases. Because NMN sits at a junction between precursor uptake and NAD+ formation, its cellular concentration is tightly linked to enzyme activity and tissue type. NAD+ participates in redox reactions, signaling, and DNA repair, and its levels decline with age in some animal models, though human evidence remains more limited and context-dependent.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide. Its structure consists of a nicotinamide ring attached to a ribose sugar that carries a phosphate group. The molecular formula is C11H15N2O8P, and the molar mass is about 334.22 grams per mole. In cells, NMN is an intermediate in the salvage pathway that recycles nicotinamide to maintain NAD+ levels. It is not the same compound as NAD+, although it is a direct precursor in one enzymatic step.
Inside cells, the enzyme nicotinamide phosphoribosyltransferase, or NAMPT, converts nicotinamide and a ribose-phosphate donor into NMN. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+. NAD+ participates in redox reactions and serves as a substrate for signaling enzymes such as sirtuins, PARPs, and CD38. Because NAD+ levels tend to decline with age in many organisms, NMN has drawn interest as a possible way to influence that decline. Whether oral NMN reliably raises NAD+ in human tissues, and whether any such change modifies disease risk, remain open research questions.
NMN is present in small amounts in some foods, including certain vegetables, fruits, and animal products, but food content varies widely and is not well standardized. In laboratory research, NMN is used as a tool compound to study NAD+ metabolism, mitochondrial function, and cellular stress responses. Animal studies have reported changes in NAD+ levels and various physiological measures after NMN administration, but species differences and study designs limit direct extrapolation to humans. Human trials have largely focused on safety, tolerability, and pharmacokinetics, with fewer studies examining clinical endpoints.
=== Sources === Beynon, Erdmann Doane (May 1, 1938). "The Voodoo Cult among Negro migrants in Detroit". American Journal of Sociology. 43 (6): 894–907. doi:10.1086/217872. JSTOR 2768686. S2CID 144039917. Evanzz, Karl (2011) [1999]. The Messenger: The Rise and Fall of Elijah Muhammad (3 ed.). New York City, New York, United States: Knopf Doubleday. ISBN 9780307805201 – via Google Books. Gardell, Mattias (1996). In the Name of Elijah Muhammad: Louis Farrakhan and The Nation of Islam. Durham: Duke University Press. ISBN 978-0822318453.
== Other poisonous plants == Many other plants not commonly used in food or drink are also poisonous, and care should be taken to avoid accidentally contacting or ingesting them. Some of these are popular ornamental plants or are cultivated for purposes other than consumption.
=== On the heart === Myostatin is expressed at very low levels in cardiac myocytes. Although its presence has been noted in cardiomyocytes of both fetal and adult mice, its physiological function remains uncertain. However, it has been suggested that fetal cardiac myostatin may play a role in early heart development. Myostatin is produced as promyostatin, a precursor protein kept inactive by the latent TGF-β binding protein 3 (LTBP3). Pathological cardiac stress promotes N-terminal cleavage by furin convertase to create a biologically active C-terminal fragment. The mature myostatin is then segregated from the latent complex via proteolytic cleavage by BMP-1 and tolloid metalloproteinases. Free myostatin is able to bind its receptor, ActRIIB, and increase SMAD2/3 phosphorylation. The latter produces a heteromeric complex with SMAD4, inducing myostatin translocation into the cardiomyocyte nucleus to modulate transcription factor activity. Manipulating the muscle creatinine kinase promoter can modulate myostatin expression, although it has only been observed in male mice thus far. Myostatin may inhibit cardiomyocyte proliferation and differentiation by manipulating cell cycle progression. This argument is supported by the fact that myostatin mRNA is poorly expressed in proliferating fetal cardiomyocytes. In vitro studies indicate that myostatin promotes SMAD2 phosphorylation to inhibit cardiomyocyte proliferation.
== History == The term was first suggested in 1980, as connective tissue disease in patients whose features did not meet other classification criteria. In 1999, a study noted, "In recent years, there has been growing concern regarding the diagnosis of incomplete forms of the autoimmune diseases" and the first classification criteria were proposed in that year. Historically, the condition was sometimes called undifferentiated connective tissue syndrome, latent lupus, or incomplete lupus.
=== Alliance of governors === In November 2024, Pritzker and other U.S. state governors established Governors Safeguarding Democracy, an alliance to protect state interests against anticipated changes in the federal government.
Sources: en.wikipedia.org
atomic) nature of matter and the possibility of exponential growth, this stage is seen as the basis of another industrial revolution. There are currently many different approaches to building productive nanosystems: including top-down approaches like Patterned atomic layer epitaxy and Diamondoid Mechanosynthesis. There are also bottom-up approaches like DNA Origami and Bis-peptide Synthesis. A fifth step, info/bio/nano convergence, was later introduced by Roco as the convergence of the three most revolutionary technologies according to Roco.
Colombia has more than 3,950 research groups in science and technology. iNNpulsa, a government body that promotes entrepreneurship and innovation in the country, provides grants to startups, in addition to other services it and institutions provide. Colombia was ranked 71st in the Global Innovation Index in 2025. Co-working spaces have arisen to serve as communities for startups large and small. Organizations such as the Corporation for Biological Research (CIB) for the support of young people interested in scientific work has been successfully developed in Colombia. The International Center for Tropical Agriculture based in Colombia investigates the increasing challenge of global warming and food security. Important inventions related to medicine have been made in Colombia, such as the first external artificial pacemaker with internal electrodes, invented by the electrical engineer Jorge Reynolds Pombo, an invention of great importance for those who suffer from heart failure. Also invented in Colombia were the microkeratome and keratomileusis technique, which form the fundamental basis of what now is known as LASIK (one of the most important techniques for the correction of refractive errors of vision) and the Hakim valve for the treatment of hydrocephalus. Colombia has begun to innovate in military technology for its army and other armies of the world; especially in the design and creation of personal ballistic protection products, military hardware, military robots, bombs, simulators and radar. Some leading Colombian scientists are Joseph M.
== Awards and honours == 2007 Donald F. Steiner Award for Outstanding Diabetes Research, University of Chicago 2008 Prix Galien Canada for Outstanding Pharmaceutical Research 2009 Clinical Investigator Award, Endocrine Society 2012 Claude Bernard Prize, European Association for the Study of Diabetes 2012 Fellow of the Royal Society of Canada 2013 Oon International Award for Preventative Medicine, University of Cambridge 2014 Banting Medal for Scientific Achievement, American Diabetes Association 2014 Manpei Suzuki Foundation International Prize for Diabetes, Japan 2015 Fellow of the Royal Society 2015 Officer of the Order of Canada 2017 Rolf Luft Award in Endocrinology and Diabetes Research, Karolinska Institute 2017 Harrington Prize for Innovation in Medicine, American Society for Clinical Investigation and the Harrington Institute (co-recipient with Joel Habener and Jens Juul Holst) 2019 Harold Hamm International Prize for Biomedical Research in Diabetes 2019 Novo Nordisk Foundation and European Association for the Study of Diabetes Prize for Excellence in Diabetes Research (watch the mini documentary about Drucker produced by the Novo Nordisk Foundation for the occasion) 2019 Lifetime Achievement Award, Helmholtz Diabetes Centre, Germany 2020 John Baxter Award for Entrepreneurship, Endocrine Society 2020 Transatlantic Medal, Society for Endocrinology 2020 Warren Alpert Foundation Prize for Biomedical Research (co-recipient with Joel Habener and Jens Juul Holst) 2021 International Member, National Academy of Sciences 2021 Canada Gairdner International Award (co-recipient with Joel Habener and Jens Juul Holst) 2022 Inductee of the Canadian Medical Hall of Fame 2023 Wolf Prize in Medicine 2023 International Member of the National Academy of Medicine 2023 VinFuture Prize for Innovators with Outstanding Achievements in Emerging Fields (co-recipient with Joel Habener, Jens Juul Holst and Svetlana Mojsov) 2024 Princess of Asturias Award for Technical and Scientific Research (co-recipient with Jeffrey M. Friedman, Joel Habener, Jens Juul Holst and Svetlana Mojsov) 2024 Time100 Most Influential People and Time100 Health 2024 Golden Plate Award, American Academy of Achievement 2024 Fred Conrad Koch Lifetime Achievement Award, Endocrine Society 2024 TOPS Research Achievement Award, The Obesity Society 2025 Warren Triennial Prize, Massachusetts General Hospital (co-recipient with Joel Habener and Svetlana Mojsov) 2025 BBVA Foundation Frontiers of Knowledge Award in Biology and Biomedicine (co-recipient with Joel Habener, Jens Juul Holst and Svetlana Mojsov) 2025 Solomon A. Berson Award, American Physiology Society 2025 Breakthrough Prize in Life Sciences (co-recipient with Joel Habener, Jens Juul Holst, Svetlana Mojsov and Lotte Bjerre Knudsen) 2026 Governor General's Innovation Award
2 MoS2 + 7 O2 → 2 MoO3 + 4 SO2 The trioxide, which is volatile at high temperatures, is the precursor to virtually all other Mo compounds as well as alloys. Molybdenum has several oxidation states, the most stable being +4 and +6 (bolded in the table at left). Molybdenum(VI) oxide is soluble in strong alkaline water, forming molybdates (MoO42−). Molybdates are weaker oxidants than chromates. They tend to form structurally complex oxyanions by condensation at lower pH values, such as [Mo7O24]6− and [Mo8O26]4−. Polymolybdates can incorporate other ions, forming polyoxometalates. The dark-blue phosphorus-containing heteropolymolybdate P[Mo12O40]3− is used for the spectroscopic detection of phosphorus. The broad range of oxidation states of molybdenum is reflected in various molybdenum chlorides:
Sources: en.wikipedia.org
=== Former programming === Formerly, Bryant Park hosted New York Fashion Week (NYFW) shows, which took over the park for two weeks in the winter and late summer each year. NYFW, which moved to Bryant Park in 1993, was forced to set fees for its shows after Manhattan Community Board 5 disapproved of a free fashion show on the grounds that three-fourths of profits would go to BPC and only one-fourth to NYC Parks. Dan Biederman of the BPC had called the profits from NYFW "a million dollars I would happily do without," and lamented the fact that NYFW took over the park at two high-traffic periods: late summer and late winter. NYFW moved from Bryant Park in 2010 after disagreements with the BPC.
Some hemoglobinopathies seem to have given an evolutionary benefit, especially to heterozygotes, in areas where malaria is endemic. Malaria parasites infect red blood cells, but subtly disturb normal cellular function and subvert the immune response. A number of mechanisms have been proposed to explain the increased chance of survival for the carrier of an abnormal hemoglobin trait.
Gross report to have evidenced and quantified DMT, along with its structural analog bufotenin (5-HO-DMT), in human blood and urine. In an article published four months later, the method used in their study was strongly criticized, and the credibility of their results challenged. Few of the analytical methods used prior to 2001 to measure levels of endogenously formed DMT had enough sensitivity and selectivity to produce reliable results. Gas chromatography, preferably coupled to mass spectrometry (GC-MS), is considered a minimum requirement. A study published in 2005 implements the most sensitive and selective method ever used to measure endogenous DMT: liquid chromatography-tandem mass spectrometry with electrospray ionization (LC-ESI-MS/MS) allows for reaching limits of detection (LODs) 12 to 200 fold lower than those attained by the best methods employed in the 1970s. The data summarized in the table below are from studies conforming to the abovementioned requirements (abbreviations used: CSF = cerebrospinal fluid; LOD = limit of detection; n = number of samples; ng/L and ng/kg = nanograms (10−9 g) per litre, and nanograms per kilogram, respectively):
Sources: en.wikipedia.org
NMN is nicotinamide mononucleotide, a nucleotide intermediate in NAD+ metabolism. It occurs naturally in cells and can also be produced synthetically for research or commercial use. Its name reflects its composition: nicotinamide, ribose, and a phosphate group.
NMN is a direct precursor in the NAD+ salvage pathway. NMNAT enzymes convert NMN and ATP into NAD+, a coenzyme used in many cellular reactions. This relationship makes NMN a focus of studies on NAD+ metabolism.
Small amounts of NMN have been reported in some plant foods, but measured levels vary and are not consistently quantified. Dietary contribution is generally considered minor compared with endogenous production. Food-matrix effects make accurate analysis difficult.
NMN stands for nicotinamide mononucleotide. It is a naturally occurring nucleotide and an intermediate in NAD+ biosynthesis.